Close Menu

NEW YORK (360Dx) – Nightingale Health said on Monday that it will analyze biomarker profiles in the blood samples of 150,000 participants in a Mexico City Prospective Study being conducted to track diseases in a Hispanic population.

Nightingale said that as part of the study, it will perform large-scale metabolic profiling under a contract with the Nuffield Department of Population Health at the University of Oxford in the UK.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.